Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

User-Fee Facts: 10 Key Medtech Details From US FDA Agreements

May 11 2017

• By David Filmore

Businessman looking through a magnifying glass to documents

Related Content

Bill Bonanza: US Congress Sprouts Medtech Legislation This Spring

May 02 2017

FDA 'Cures' Fund Breakdown: Breakthrough Devices, HDEs, IRB Flexibility And More

May 09 2017

Single Marketing Application Review For Multiple Jurisdictions On Horizon

Apr 06 2017

MDR Reporting: FDA Embraces Adverse Event Summaries Under MDUFA IV, But Flouts Similar FDAAA Mandate

Jan 05 2017

FDA Tries To Get 'Smart' In Standardizing 510(k) Reviews

Nov 04 2015

'Cures' Bill Circumvents FDA On Medical Software Regs

Nov 30 2016

Must-Do Guidance Development: What's On Tap From Cures, MDUFA IV

Dec 22 2016

Device Standards Provision In Cures Bill Could Speed Up 510(k) Clearances

Dec 01 2016

Industry, US FDA Strike $1Bn Deal After Contentious User-Fee Negotiations

Aug 23 2016

PDUFA First: Fees To Support US FDA Device Center Staff

Aug 25 2016

US Device User-Fee Rates Will Drop About 10.3% In Fiscal 2017

Aug 01 2016

Additional Topics

United States Regulation FDA Legislation Medical Device In Vitro Diagnostics

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window